California Healthcare Institute Announces Agenda, Speakers for CHI 2012

Share Article

Former Congressman Tom Campbell to Keynote Annual Meeting, Nov. 8

CHI-California Healthcare Institute today announced that Tom Campbell, Ph.D., a former U.S. congressman and state senator who serves as dean of the Chapman University School of Law, will give the keynote address for CHI 2012, the annual meeting of CHI. CHI 2012 focuses on the relationship between biomedical innovation and public policy. The goal of the meeting is to highlight the biomedical community’s work and needs in the context of the November election, and to discuss how the industry can sustain California’s leadership in medical innovation.

Campbell, who was a member of the California Senate before serving two terms in Congress ending in 2001, will provide CHI 2012 attendees with economic analysis based on the election, and share insights on the future of healthcare legislation and the political process. Campbell has taught at UC Berkeley, where, during his tenure, The Wall Street Journal boosted the Haas School of Business ranking from 15th to 2nd. He also served as a professor at Stanford Law School. Campbell graduated with a doctorate degree in economics from the University of Chicago. He received his law degree from Harvard Law School.

The event, taking place on Thursday, Nov. 8, from 8 a.m. to 6 p.m., on the Gilead Sciences Campus in Foster City, will bring together hundreds of leading executives from biotechnology, medical device and pharmaceutical companies, as well as leaders from the state’s academic research community with policy makers to discuss critical issues and opportunities facing the biomedical community.

“This event, immediately after a pivotal election, will serve as a forum for generating ideas to support and strengthen the biomedical community,” said CHI President and CEO David L. Gollaher, Ph.D. “California’s engine for biomedical creativity leads the world, but we confront an extraordinarily challenging political and economic environment.”

The forum is intended for top-level biomedical industry executives, leaders from California's academic research community, entrepreneurs, investors, federal and state policy makers, members of the media and key federal, state and local legislative staff. Visit for the latest speaker line-up, agenda and additional event details or to register.

Agenda At A Glance:

8 to 9 a.m.
Networking breakfast and registration

9 to 10 a.m.
Decision 2012: Understanding the Outcome of the Election

10 to 10:30 a.m.

  • Dr. Mark Smith, President & CEO, California HealthCare Foundation

10:30 to 11:30 a.m.
Regulatory Approaches to Benefit and Risk: A Global Perspective

  • Moderator: Coleen Klasmeier, Head, FDA Regulatory Practice, Sidley Austin
  • Dr. Scott Gottlieb, Resident Fellow, American Enterprise Institute
  • Michael Narachi, President & CEO, Orexigen
  • Vincenzo Salvatore, Senior Counsel, Sidley Austin LLP

11:30 a.m. to 1 p.m.
Luncheon Keynote

  • Tom Campbell, Dean of the School of Law, Chapman University

1 to 2 p.m.
California and the Affordable Care Act

  • Daniel Mendelson, CEO and Founder, Avalere

2 to 2:30 p.m.
Salon Interactive

2:30 to 3 p.m.

3 to 4 p.m.
Economic and Public Health Impact of Federal Funding of Basic Research

  • Dr. Michael Friedman, CEO, Director, Comprehensive Cancer Center,

4 to 5 p.m.
The Innovation Continuum: Balancing Stakeholder Demands

  • Bryan Giraudo, Managing Partner, Leerink Swann

5 to 6 p.m.

Register at by Sept. 16 for early bird savings. For additional savings, visit and click on the QR code for a 20 percent discount on registration and a chance to win a free night stay at The San Francisco Sofitel Bay Hotel on Nov. 8.

Complimentary registration and full access to CHI 2012 are reserved for working members of the media, including print, broadcast and online media. Credentialed members of the media may register to attend the conference and are required to provide CHI staff with a copy of their press credentials and letters of assignment. Contact CHI’s Senior Communications Specialist Heather Chambers (858-456-8885 or chambers(at)chi(dot)org.

Early bird (on or before Sept. 16):
$199 Academic/government/non-profit
$225 Emerging Enterprise Program Member
$449 Member
$849 Non-member

After Sept. 16:
$199 Academic/government/non-profit
$425 CHI Emerging Enterprise Program Member
$849 Member
$1,249 Non-member

Onsite subject to availability:
$349 Academic/government/non-profit
$525 CHI Emerging Enterprise Program Member
$1,049 Member
$1,449 Non-member

Click here to register.

Hotel Information:
CHI has reserved a block of rooms at The Sofitel San Francisco Bay Hotel. The deadline to receive the negotiated rate of $169 is Friday, Oct. 19. Please contact the hotel reservation line at 650-598-9000 and provide the California Healthcare Institute name in order to receive the negotiated rate.

CHI would like to thank its Platinum Sponsors Hologic + Gen-Probe and Gilead Sciences; Gold Sponsors Boston Scientific, Ernst & Young, Leerink Swann and Sidley Austin LLP; Silver Sponsors Abbott, Alexandria Real Estate Equities, Aptiv Solutions, Biogen Idec, Forest Laboratories, Genentech, Genzyme, Mentor, Pfizer, ResMed and St. Jude Medical; and Student Scholarship Sponsor BD. Sponsorships are still available at various levels to fit with your marketing plan. Contact CHI Vice President of Business Development Molly Ingraham for more information (858-456-8884 or Ingraham(at)chi(dot)org.

About CHI
CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is Follow us on Twitter @calhealthcare, Facebook, LinkedIn and YouTube.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Heather Chambers
Follow us on